首页> 外文会议>Falk Symposium >Adaptive hepatobiliary transporter regulation by ursodeoxycholic acid
【24h】

Adaptive hepatobiliary transporter regulation by ursodeoxycholic acid

机译:铀酰胆酸的适应性肝胆转运仪调节

获取原文

摘要

Cholestasis is associated with impaired expression and function of hepatic uptake (Ntcp/SlclOal, Oatp/SIc21a) and excretory systems (Bsep/Abcbll, Mrp2/Abcc2) for bile acids and other organic anions in rodents, changes which may maintain and contribute to cholestasis. Moreover, adaptive transporter changes such as induction of alternative efflux pumps in liver (Mrp3/Abcc3, Mrp4/Abcc4) and kidney (Mrp2, Mrp4) may help to limit hepatic accumulation of potentially toxic biliary constituents in cholestasis by providing alternative escape routes. In line with these observations in rodent models of cholestasis, similar findings (down-regulation of NTCP, 0ATP2/0ATP-C/ SLC21A6; induction of MRP3, MRP4) have been obtained in livers from patients with cholestatic liver diseases (e.g. PBO).
机译:胆汁淤积与肝脏摄取(NTCP /脚踏,OATP / SIC21A)和排泄系统(BSEP / ABCBLL,MRP2 / ABCC2)的表达和功能有关,用于啮齿动物和啮齿动物中的其他有机阴离子,可能保持和促成胆汁淤积的变化。此外,诸如肝脏(MRP3 / ABCC3,MRP4 / ABCC4)和肾(MRP2,MRP4)和肾脏(MRP2,MRP4)诱导的适应性转运蛋白的变化可能有助于通过提供替代逃避途径来限制胆汁淤积中可能有毒胆道成分的肝积累。根据胆汁淤积症的类似发现(NTCP,0ATP2 / 0ATP-C / SLC21A6的啮齿动物模型中的这些观察结果符合这些观察结果。从胆汁肝病(例如PBO)的肝脏中,已经在肝脏肝脏中获得了肝脏的诱导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号